Filing Details
- Accession Number:
- 0001209191-19-057197
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 16:42:54
- Reporting Period:
- 2019-08-19
- Accepted Time:
- 2019-11-19 16:42:54
- Original Submission Date:
- 2019-08-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 462702363 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1757964 | Robert Paul | C/O Alector, Inc. 131 Oyster Point Blvd, Suite 600 South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-19 | 1,084 | $8.16 | 324,803 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-19 | 1,084 | $16.00 | 323,719 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-20 | 916 | $8.16 | 324,635 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-20 | 916 | $16.00 | 323,719 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-08-19 | 1,084 | $0.00 | 1,084 | $8.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-08-20 | 916 | $0.00 | 916 | $8.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 348,916 | 2028-07-01 | No | 4 | M | Direct | |
| 348,000 | 2028-07-01 | No | 4 | M | Direct |
Footnotes
- The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
- One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Billionaire Hedge Funds
